01153nam a2200193   4500001000700000010001500007100004100022101000800063200012700071210008300198215001700281330050100298606002200799606004100821606001700862606000900879606001100888710006000899384321  a9291680613  a20070531d1999       y0pory50      ba  aeng  aGuidelines for the risk assessment of new synthetic drugsfEuropean Monitoring Centre for Drugs and Drug Addiction, EMCDDA  aLuxembourgcOffice for Official Publications of the European Communitiesd1999  a33 p.d21 cm  aForeword. Introduction. Chapter 1 - Basic principles for risk assessment. Chapter 2 - A conceptual framework for risk assessment. Chapter 3 - Quality of information for risk assessment. Chapter 4 - Headings for risk assessment. Technical annex A - Pharmacotoxicological evidence. Technical annex B - Psychological risk assessment (cognition, mood and mental functioning). Technical annex C - Sociological/criminological evidence. Technical annex D - Public health risks: epidemiological evidence.  aDROGA SINTÉTICA  aPREVENÇÃO DA TOXICODEPENDÊNCIA  aMETODOLOGIAS  aOEDT  aEMCDDA  aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION